Holocene Advisors’s AtriCure ATRC Stock Holding History

Holocene Advisors’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-81,853	Closed	-$2.49M	–	695
2024 Q1	$2.49M	Buy	+81,853	New	+$2.74M	0.01%	545

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Holocene Advisors's ATRC Position: Q2 2024 in Review

Holocene Advisors sold out of AtriCure (ATRC) in Q2 2024, closing a stake of 81,853 shares — an estimated $2.49M sold.

Holocene Advisors first reported a position in ATRC in Q1 2024 and held it in 1 quarter. The position peaked at $2.49M in Q1 2024. 197 funds tracked by Wall St. Rank hold ATRC as of Q2 2024.

Holocene Advisors reported no remaining AtriCure position as of Q2 2024 after selling out during the quarter.
Holocene Advisors sold 81,853 AtriCure shares in Q2 2024, an estimated $2.49M.
Holocene Advisors first reported a position in AtriCure in Q1 2024 and held it in 1 quarter.
Holocene Advisors's AtriCure position peaked at $2.49M in Q1 2024.
197 funds tracked by Wall St. Rank held AtriCure as of Q2 2024.

Based on Holocene Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.